Table 1.
Patients’ characteristics
| Non-hypotension (n = 19) | Hypotension (n = 75) | p value | |
|---|---|---|---|
| Age (years) | 50.2 ± 14.7 | 57.9 ± 10.7 | 0.01 |
| Sex (male, %) | 14 (73.7) | 36 (48.0) | 0.05 |
| ASA physical status | 0.07 | ||
| I | 11 (57.9) | 26 (34.7) | |
| II | 8 (42.1) | 49 (65.3) | |
| Comorbidities | 0.247 | ||
| Hypertension | 2 (10.5) | 20 (26.7) | 0.140 |
| Diabetes mellitus | 1 (5.3) | 7 (9.3) | 0.572 |
| Hypertension and diabetes mellitus all | 4 (21.1) | 12 (16) | 0.603 |
| Coronary artery disease | 0 (0) | 1 (1.3) | 0.615 |
| Cerebrovascular disease | 0 (0) | 2 (2.7) | 0.474 |
| Propofol dose (mg) | 108.9 (23.0) | 118.4(21.2) | 0.091 |
| Cumulative remifentanil dose (mcg) | 68.8 [27.3–88.6] | 74.7 [62.5–89.9] | 0.694 |
| Lung compliance (ml/cmH20) | 59.4 ± 12.4 | 52.5 ± 13.1 | 0.252 |
Values are presented as mean ± standard deviation, a number of patients (%), or median [interquartile range]
ASA American Society of Anesthesiologists